EMPIRE STATE REALTY TRUST-A (ESRT) Stock Fundamental Analysis

NYSE:ESRT • US2921041065

6.27 USD
-0.07 (-1.1%)
At close: Feb 13, 2026
6.27 USD
0 (0%)
After Hours: 2/13/2026, 8:05:34 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, ESRT scores 4 out of 10 in our fundamental rating. ESRT was compared to 123 industry peers in the Diversified REITs industry. ESRT has an average financial health and profitability rating. ESRT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year ESRT was profitable.
  • ESRT had a positive operating cash flow in the past year.
  • In multiple years ESRT reported negative net income over the last 5 years.
  • In the past 5 years ESRT always reported a positive cash flow from operatings.
ESRT Yearly Net Income VS EBIT VS OCF VS FCFESRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • With a Return On Assets value of 0.85%, ESRT perfoms like the industry average, outperforming 52.46% of the companies in the same industry.
  • ESRT has a Return On Equity (3.25%) which is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 2.87%, ESRT is in line with its industry, outperforming 54.10% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for ESRT is in line with the industry average of 3.07%.
  • The 3 year average ROIC (2.75%) for ESRT is below the current ROIC(2.87%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.85%
ROE 3.25%
ROIC 2.87%
ROA(3y)1.03%
ROA(5y)0.49%
ROE(3y)4.33%
ROE(5y)2.08%
ROIC(3y)2.75%
ROIC(5y)2.24%
ESRT Yearly ROA, ROE, ROICESRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4

1.3 Margins

  • The Profit Margin of ESRT (4.55%) is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of ESRT has declined.
  • ESRT has a Operating Margin (18.68%) which is in line with its industry peers.
  • ESRT's Operating Margin has been stable in the last couple of years.
  • The Gross Margin of ESRT (54.04%) is worse than 72.95% of its industry peers.
  • ESRT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.68%
PM (TTM) 4.55%
GM 54.04%
OM growth 3Y14.11%
OM growth 5Y-0.46%
PM growth 3YN/A
PM growth 5Y-1.77%
GM growth 3Y-0.96%
GM growth 5Y-0.19%
ESRT Yearly Profit, Operating, Gross MarginsESRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • ESRT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for ESRT has been increased compared to 1 year ago.
  • ESRT has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ESRT is higher compared to a year ago.
ESRT Yearly Shares OutstandingESRT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ESRT Yearly Total Debt VS Total AssetsESRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • ESRT has an Altman-Z score of 0.58. This is a bad value and indicates that ESRT is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.58, ESRT is in line with its industry, outperforming 52.46% of the companies in the same industry.
  • A Debt/Equity ratio of 1.92 is on the high side and indicates that ESRT has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.92, ESRT is doing worse than 68.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF N/A
Altman-Z 0.58
ROIC/WACC0.49
WACC5.92%
ESRT Yearly LT Debt VS Equity VS FCFESRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

  • ESRT has a Current Ratio of 2.59. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
  • ESRT's Current ratio of 2.59 is amongst the best of the industry. ESRT outperforms 89.34% of its industry peers.
  • ESRT has a Quick Ratio of 2.59. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
  • ESRT's Quick ratio of 2.59 is amongst the best of the industry. ESRT outperforms 89.34% of its industry peers.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 2.59
ESRT Yearly Current Assets VS Current LiabilitesESRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • ESRT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.50%, which is quite impressive.
  • Measured over the past years, ESRT shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.83% on average per year.
  • The Revenue has been growing slightly by 0.45% in the past year.
  • Measured over the past years, ESRT shows a small growth in Revenue. The Revenue has been growing by 0.98% on average per year.
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5Y-8.83%
EPS Q2Q%187.5%
Revenue 1Y (TTM)0.45%
Revenue growth 3Y7.16%
Revenue growth 5Y0.98%
Sales Q2Q%-20.64%

3.2 Future

  • ESRT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -37.27% yearly.
  • ESRT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.75% yearly.
EPS Next Y-88.67%
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%
EPS Next 5Y-37.27%
Revenue Next Year0.75%
Revenue Next 2Y1.81%
Revenue Next 3Y1.71%
Revenue Next 5Y1.75%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ESRT Yearly Revenue VS EstimatesESRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
ESRT Yearly EPS VS EstimatesESRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 7.12 indicates a rather cheap valuation of ESRT.
  • Based on the Price/Earnings ratio, ESRT is valued cheaply inside the industry as 95.08% of the companies are valued more expensively.
  • ESRT is valuated cheaply when we compare the Price/Earnings ratio to 27.97, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 102.45, ESRT can be considered very expensive at the moment.
  • ESRT's Price/Forward Earnings ratio is in line with the industry average.
  • ESRT is valuated expensively when we compare the Price/Forward Earnings ratio to 27.96, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.12
Fwd PE 102.45
ESRT Price Earnings VS Forward Price EarningsESRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • ESRT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ESRT is cheaper than 91.80% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.96
ESRT Per share dataESRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • A cheap valuation may be justified as ESRT's earnings are expected to decrease with -56.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • ESRT has a Yearly Dividend Yield of 2.21%.
  • With a Dividend Yield of 2.21, ESRT pays less dividend than the industry average, which is at 6.82. 84.43% of the companies listed in the same industry pay a better dividend than ESRT!
  • ESRT's Dividend Yield is a higher than the S&P500 average which is at 1.84.
Industry RankSector Rank
Dividend Yield 2.21%

5.2 History

  • The dividend of ESRT decreases each year by -17.38%.
  • ESRT has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ESRT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-17.38%
Div Incr Years0
Div Non Decr Years3
ESRT Yearly Dividends per shareESRT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

  • ESRT pays out 79.65% of its income as dividend. This is not a sustainable payout ratio.
  • ESRT's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP79.65%
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%
ESRT Yearly Income VS Free CF VS DividendESRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M
ESRT Dividend Payout.ESRT Dividend Payout, showing the Payout Ratio.ESRT Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

EMPIRE STATE REALTY TRUST-A

NYSE:ESRT (2/13/2026, 8:05:34 PM)

After market: 6.27 0 (0%)

6.27

-0.07 (-1.1%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-29
Earnings (Next)02-17
Inst Owners100.46%
Inst Owner Change-1.38%
Ins Owners0.08%
Ins Owner Change0%
Market Cap1.07B
Revenue(TTM)766.65M
Net Income(TTM)34.89M
Analysts75
Price Target8.12 (29.51%)
Short Float %3.35%
Short Ratio4.14
Dividend
Industry RankSector Rank
Dividend Yield 2.21%
Yearly Dividend0.17
Dividend Growth(5Y)-17.38%
DP79.65%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.01%
PT rev (3m)-10.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 7.12
Fwd PE 102.45
P/S 1.39
P/FCF N/A
P/OCF 4.02
P/B 0.99
P/tB 3.89
EV/EBITDA 8.96
EPS(TTM)0.88
EY14.04%
EPS(NY)0.06
Fwd EY0.98%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)1.56
OCFY24.85%
SpS4.5
BVpS6.31
TBVpS1.61
PEG (NY)N/A
PEG (5Y)N/A
Graham Number11.18
Profitability
Industry RankSector Rank
ROA 0.85%
ROE 3.25%
ROCE 3.64%
ROIC 2.87%
ROICexc 2.99%
ROICexgc 3.79%
OM 18.68%
PM (TTM) 4.55%
GM 54.04%
FCFM N/A
ROA(3y)1.03%
ROA(5y)0.49%
ROE(3y)4.33%
ROE(5y)2.08%
ROIC(3y)2.75%
ROIC(5y)2.24%
ROICexc(3y)2.99%
ROICexc(5y)2.46%
ROICexgc(3y)3.81%
ROICexgc(5y)3.15%
ROCE(3y)3.48%
ROCE(5y)2.83%
ROICexgc growth 3Y18.9%
ROICexgc growth 5Y-2.68%
ROICexc growth 3Y19.87%
ROICexc growth 5Y-1.77%
OM growth 3Y14.11%
OM growth 5Y-0.46%
PM growth 3YN/A
PM growth 5Y-1.77%
GM growth 3Y-0.96%
GM growth 5Y-0.19%
F-Score6
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF N/A
Debt/EBITDA 6.18
Cap/Depr 140.72%
Cap/Sales 34.79%
Interest Coverage 1.49
Cash Conversion 79.7%
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 2.59
Altman-Z 0.58
F-Score6
WACC5.92%
ROIC/WACC0.49
Cap/Depr(3y)133.09%
Cap/Depr(5y)115.91%
Cap/Sales(3y)34.64%
Cap/Sales(5y)32.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5Y-8.83%
EPS Q2Q%187.5%
EPS Next Y-88.67%
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%
EPS Next 5Y-37.27%
Revenue 1Y (TTM)0.45%
Revenue growth 3Y7.16%
Revenue growth 5Y0.98%
Sales Q2Q%-20.64%
Revenue Next Year0.75%
Revenue Next 2Y1.81%
Revenue Next 3Y1.71%
Revenue Next 5Y1.75%
EBIT growth 1Y-8.53%
EBIT growth 3Y22.28%
EBIT growth 5Y0.51%
EBIT Next Year124.48%
EBIT Next 3Y34.61%
EBIT Next 5Y20.13%
FCF growth 1Y96.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.72%
OCF growth 3Y7.08%
OCF growth 5Y2.32%

EMPIRE STATE REALTY TRUST-A / ESRT FAQ

Can you provide the ChartMill fundamental rating for EMPIRE STATE REALTY TRUST-A?

ChartMill assigns a fundamental rating of 4 / 10 to ESRT.


What is the valuation status for ESRT stock?

ChartMill assigns a valuation rating of 4 / 10 to EMPIRE STATE REALTY TRUST-A (ESRT). This can be considered as Fairly Valued.


What is the profitability of ESRT stock?

EMPIRE STATE REALTY TRUST-A (ESRT) has a profitability rating of 4 / 10.


What is the valuation of EMPIRE STATE REALTY TRUST-A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EMPIRE STATE REALTY TRUST-A (ESRT) is 7.12 and the Price/Book (PB) ratio is 0.99.


What is the financial health of EMPIRE STATE REALTY TRUST-A (ESRT) stock?

The financial health rating of EMPIRE STATE REALTY TRUST-A (ESRT) is 4 / 10.